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ABSTRACT Aldosterone-dependent epithelial sodium
transport in the distal nephron is mediated by the absorption
of sodium through the highly selective, amiloride-sensitive
epithelial sodium channel (ENaC) made of three homologous
subunits (a, b, and g). In human, autosomal recessive mu-
tations of a, b, or gENaC subunits cause pseudohypoaldo-
steronism type 1 (PHA-1), a renal salt-wasting syndrome
characterized by severe hypovolemia, high plasma aldoste-
rone, hyponatremia, life-threatening hyperkaliemia, and met-
abolic acidosis. In the mouse, inactivation of aENaC results in
failure to clear fetal lung liquid at birth and in early neonatal
death, preventing the observation of a PHA-1 renal phenotype.
Transgenic expression of aENaC driven by a cytomegalovirus
promoter in aENaC(2y2) knockout mice [aENaC(2y2)Tg]
rescued the perinatal lethal pulmonary phenotype and par-
tially restored Na1 transport in renal, colonic, and pulmonary
epithelia. At days 5–9, however, aENaC(2y2)Tg mice showed
clinical features of severe PHA-1 with metabolic acidosis,
urinary salt-wasting, growth retardation, and 50% mortality.
Adult aENaC(2y2)Tg survivors exhibited a compensated
PHA-1 with normal acidybase and electrolyte values but
6-fold elevation of plasma aldosterone compared with wild-
type littermate controls. We conclude that partial restoration
of ENaC-mediated Na1 absorption in this transgenic mouse
results in a mouse model for PHA-1.
In mammals, sodium homeostasis is mainly maintained by
regulation of electrogenic sodium reabsorption in kidney.
Sodium is reabsorbed from urine through highly selective,
amiloride-sensitive sodium channels (ENaC) (1). Located in
the apical membrane of cortical collecting duct cells in the
distal nephron (2), ENaC constitutes the limiting step for
transepithelial sodium transport whereas the Na, K-ATPase
located in the basolateral membrane provides the driving force
(3). Electrogenic sodium transport is controlled by aldoste-
rone, thereby promoting sodium reabsorption and potassium
excretion by aldosterone-target cells like in the distal nephron
or the distal part of the colon (2). There is a tight relationship
among sodium balance, extracellular fluid volume, plasma
aldosterone levels, and blood pressure. After a normal or high
salt diet, plasma concentrations of aldosterone are low, and
ENaC-mediated electrogenic sodium transport is not detect-
able, as shown in rat (4). By contrast, in rats maintained on a
low salt diet, plasma concentration of aldosterone increases
rapidly, and electrogenic sodium transport is induced. A
similar response is well documented in distal colon (5). Despite
large changes in water and salt intake, this precise hormonal
regulation maintains the extracellular osmolality and blood
volume within narrow margins (6).
Genetic evidence for direct involvement of ENaC in sodium
balance came from the observation that mutations in subunits
of ENaC cause two human genetic diseases, Liddle syndrome
and the autosomal recessive form of pseudohypoaldosteron-
ism (PHA-1). Liddle syndrome is characterized by early onset
of hypertension associated with normal plasma aldosterone
levels whereas PHA-1 is a salt-wasting syndrome with hypo-
tension and high plasma aldosterone levels and mineralocor-
ticoid resistance in kidney, sweat, and salivary glands and in
colon mucosa (7). PHA-1 patients are therefore treated with
sodium and bicarbonate supplementation. Expression analysis
of ENaC mutations in Xenopus oocytes revealed constitutive
activation of ENaC in Liddle syndrome (8) and reduced ENaC
activity in PHA-1 patients (9, 10).
In contrast to the kidney and colon, ENaC-mediated sodium
transport in the lung is glucocorticoid-sensitive but aldoste-
rone-insensitive (11, 12). Independent of salt diet and plasma
aldosterone, a basal constitutive level of sodium transport
appears to be required for proper lung fluid clearance from
birth to adulthood. In the lung, sodium reabsorption plays an
important role at birth, when the pulmonary epithelium
switches from a basal net secretory to a basal net reabsorptive
mode. In fetal lung, all three subunits (a, b, and gENaC) are
developmentally regulated and can be induced by in vivo
administration of glucocorticoid hormones (13, 14). The crit-
ical role for ENaC in lung liquid clearance was shown in
knockout mice in which the gene locus of a subunit of ENaC
was inactivated by homologous recombination in embryonic
stem cells, thereby abolishing functioning of the channel (15).
Newborn mice deficient for aENaC died soon after birth with
water-filled lungs. The PHA-1 renal salt-wasting phenotype
was not observed in aENaC(2y2) mice, presumably because
the neonates died too early from respiratory distress syndrome.
To distinguish the physiological importance of constitutive
vs. aldosterone-dependent sodium transport by ENaC in lung,
kidney, and colon, we generated transgenic mice carrying the
a subunit of ENaC under the control of an ubiquitously and
constitutively expressed cytomegalovirus promoter on an
aENaC knockout background. The resulting mice
[aENaC(2y2)Tg] had sufficient basal Na1 absorptive capac-
ity to clear lung liquid and survive the early neonatal period
but developed a phenotype similar to PHA-1 with salt-wasting,
metabolic acidosis, high aldosterone levels, growth retarda-
tion, and increased early mortality.
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Generation and Analysis of Transgenic Mice. The transgene
vector pCisaR1 contains the cytomegalovirus promoter (16),
an IgE intron (100 mer), the SalI–EcoRV arENaC fragment
(position 278 to 12149; ref. 17), and simian virus 40 large T
antigen polyadenylation sequences. The insert was excised as
a 3.3-kb SpeI–SmaI fragment and microinjected into fertilized
oocytes (NMR1 mice). Founder animals were identified by
Southern blotting andyor PCR-based analysis of tail DNA as
described previously (refs. 15 and 18; Fig. 1a). Gender of
newborn mice was determined by using Y-specific primers
(19). To generate transgenic knockout mice [aENaC(2y
2)Tg], aENaC heterozygous mutant mice (1y2) were bred to
transgenic pCisaR1 mice and genotyped (see Fig. 1b). De-
tailed sequences for the primers are available on request.
Reverse transcription-PCR was performed as described (18)
and was controlled by detection of glyceraldehyde-3-
phosphate dehydrogenase message (Fig. 1c). In situ analysis
of aENaC mRNA was performed as described (20) using a
35S-labeled antisense riboprobe of rat aENaC subunit (po-
sition 190–542; ref. 17). Control hybridization was per-
formed with a sense aENaC riboprobe.
Analytical Procedures. Blood values were determined from
mixed blood after decapitation (newborns, 5- to 9-day-old
pups) or from arterial blood (adult mice) under anesthesia. To
measure plasma aldosterone and corticosterone concentra-
tions in adult aENaC(1y1) and (2y2)Tg mice, blood was
collected into ice-cold microcentrifuge tubes (containing
EDTA), which were centrifuged to isolate plasma. Aldoste-
rone and corticosterone assays were run in duplicate on plasma
samples. Corticosterone was determined using an 125I RIA
(detection limit 10 ngyml). Aldosterone was determined by 125I
RIA (detection limit 6 pgyml; Biodata, Cortland Manor, NY).
To measure urinary Na1yK1 from newborns and 5- to 9-day-
old pups, samples of urine were diluted into 0.1 N of nitric acid
and analyzed for Na1 and K1 by flame emission photometry.
Urinary electrolytes in adult aENaC(1y1) and (2y2)Tg
mice were measured and normalized with creatinine.
Electrophysiological Studies. Bioelectric measurements
were performed on fetal tracheal explants, freshly excised
adult tracheal and nasal epithelia, freshly excised colon epi-
thelium, and rectal epithelium in vivo. Fetal tracheal explants
were cultured for 6–8 days in F12 and 10% fetal bovine serum
(21). Transepithelial bioelectric potential difference (PD) was
measured by microelectrode puncture. Na1 transport was
determined by inhibition of basal PD after amiloride micro-
injection (1024 M) as described (21). The short circuit current
(ISC) generated by freshly excised adult tracheal and nasal
tissues and colon epithelium was measured in Ussing chambers
as described (22).
Sodium transport across the rectal epithelium was estimated
in vivo, under anesthesia, as the amiloride-sensitive rectal PD.
Rectal PD was measured between a reference electrode placed
in the s.c. tissue of the abdominal wall and a double-barreled
glass pipette placed in the rectal lumen. The first barrel of the
rectal pipette was filled with saline (isotonic NaCl buffered
with 10 mM Na1 Hepes, pH 7.2) and was connected to
AgyAgCl electrodes via plastic tubing filled with 3 M KCl in
2% agar (Q.W., E.H., M.B., J.-D.H., unpublished work); the
second barrel was filled with the same solution containing 25
mM amiloride. Rectal PD was measured after injection of 50
ml of control saline through the first barrel and after injection
of the same volume of the amiloride-containing solution
through the second barrel.
RESULTS
Rescue of Lung Phenotype. Transgenic arENaC mRNA
expression in amENaC(2y2)Tg mice was identified in lung,
kidney, skin, colon, and heart. Transcripts of b and gmENaC
subunits were present in aENaC(2y2)Tg and wild-type
(1y1) animals (Fig. 1c). Transgenic arENaC subunit expres-
sion in aENaC(2y2)Tg mice resulted in prolonged survival
(Fig. 2). The survival curve was biphasic because 8y18 (44%)
of aENaC(2y2)Tg mice (of 16 complete litters) died within
the first 2 weeks of life (Fig. 2a). The overall survival rate
among female aENaC(2y2)Tg mice was lower (11%) com-
pared with male mice (64%; Fig. 2b), which might be explained
by the X chromosomal localization of the transgene in that line
leading to X inactivation of the transgene (pCisaR1) in female
tissues (23). In situ hybridization analysis of neonatal lung (Fig.
3) showed transgenic arENaC mRNA expression in lung
airways and alveolar epithelium with a distribution and inten-
sity of expression similar to that of wild-type mice.
aENaC(2y2)Tg mice were able to clear fetal liquid (as
determined by lung water content) from the air spaces at 12 h
of age, when the lung has normally cleared most of the residual
fetal liquid (Fig. 4a). ENaC-mediated Na1 transport measured
in fetal trachea as amiloride-sensitive inhibition of PD
FIG. 1. (a) Generation of aENaC(2y2)Tg mice. (Left) pCisaR1
transgene vector containing human cytomegalovirus promoter
(hatched box) with an artificial intron (open box), rat aENaC cDNA
(black box), and simian virus 40 large T poly(A) (stippled box). S 5
SpeI; B 5 BamHI; Sm 5 SmaI. (Right, Upper) Southern blot of
BamHI-digested DNA from transgenic mouse (Tg; line 1352) and
nontransgenic control (C) littermate probed with arENaC cDNA. p,
transgene-specific fragment. (Right, Lower) PCR-based genotyping for
the transgene (651 bp*) using a set of specific primers as indicated in
a. (b) PCR-based genotyping for the gene targeting status (2y2, 1y1,
1y2) using specific primers (arrows). (c) Detection of mRNA tran-
scripts (reverse transcription-PCR) for transgene (507 bp; primers
indicated in a), aENaC, bmENaC, and gmENaC in transgenic ho-
mozygous mutant [aENaC(2y2)Tg] mice and wild-type
aENaC(1y1) mice using specific intron-spanning primers (15).
gENaC mRNA transcript in skin of aENaC(2y2)Tg mice is visible on
the original.
Physiology: Hummler et al. Proc. Natl. Acad. Sci. USA 94 (1997) 11711
(DPDamil) and in excised adult airway epithelia measured as
amiloride-sensitive short circuit current (DIscamil) were
slightly, but not significantly, decreased in aENaC(2y2)Tg
mice compared with epithelia from control mice (Fig. 4 b and
c). We therefore conclude that there was sufficient transgenic
expression of arENaC in aENaC(2y2)Tg mice to clear
newborn lungs of fetal lung liquid and to maintain liquid
balance in adult lung.
After Birth, aENaC(2y2)Tg Mice Exhibit Clinical Fea-
tures of Severe PHA-1. The decreased survival rate suggested
metabolic imbalances in the transgenic knockout mice. Acidy
base studies of mixed venous blood and measurements of
urinary sodium and potassium in neonatal mice evaluated the
effect of aENaC on renal function. From shortly after birth,
aENaC(2y2)Tg mice were generally smaller (mean weight at
5 days: 1.55 6 0.3 g, n 5 4) than littermate controls (2.0 6 0.2 g,
n 5 23). Twelve hours after birth, aENaC(2y2) mice showed
significant metabolic acidosis whereas pH and bicarbonate
concentrations in aENaC(2y2)Tg mice were normal (Fig. 5
a and b). However, by 5–9 days, aENaC(2y2)Tg mice showed
significant urinary salt-wasting [Na1] with no significant de-
crease in urinary [K1] (Fig. 5c; P , 0.05). The urinary
[Na1]y[K1] ratio was higher in the transgenic aENaC(2y2)
mice as in controls (Fig. 5d; P , 0.05). In addition to the
urinary salt wasting, 5- to 9-day-old aENaC(2y2)Tg mice
showed metabolic acidosis (Fig. 5 a and b). Because the clinical
signs of a salt-wasting syndrome were not obvious in newborn
aENaC(2y2)Tg mice, we suggest that the metabolic conse-
quences of abnormal renal Na1 absorption in aENaC(2y2)Tg
mice take '5 days to become apparent.
Adult aENaC(2y2)Tg Exhibit a Compensated PHA-1. The
aENaC(2y2)Tg adult survivors showed compensation of the
acidybase imbalances and electrolyte disturbances that were
seen in the neonatal group. Adult aENaC(2y2)Tg mice
exhibited normal values in blood (Fig. 5 a and b), serum Na1
[aENaC(2y2)Tg; n 5 8: 152.8 6 2.0 mM vs. 152.3 6 1.1 mM;
n 5 8 in wild-type mice] and serum K1 [aENaC(2y2)Tg; n 5
8: 5.8 6 0.4 mM vs. 5.3 6 0.3 mM; n 5 8 in wild-type mice],
and of urine electrolytes [Na1 and K1] (Fig. 5 c and d),
suggesting that there was a spontaneous improvement in renal
Na1 absorption over time. Adult aENaC(2y2)Tg mice were
smaller (mouse weight at 12 weeks: 35.8 6 0.8 g, n 5 15;
wild-type mice: 38.8 6 0.9 g, n 5 16; P , 0.05) although the
rate of growth in the two groups was similar after the 2nd week
(Fig. 6).
In colon, aENaC(2y2)Tg fetuses (19 days old) exhibited
lower, but not significantly different, levels of amiloride-
sensitive short circuit current (DIscamil; Fig. 7a). Responses
to intracellular cAMP agonist, forskolin, were similar in both
groups. In adults, ENaC-mediated sodium transport across
the rectal epithelium was significantly decreased. In vivo
measurements of colon PD in adults revealed a significant
lower amiloride-sensitive PD compared with wild-type lit-
termates [aENaC(1y1); Fig. 7b; P , 0.001]. This decrease
in ENaC-mediated sodium transport occurred in the context
of a significant 6-fold elevation of aldosterone levels in
aENaC(2y2)Tg mice compared with the wild-type litter-
mates (P , 0.001; Fig. 7c) whereas serum corticosterone
levels were not different in both groups (Fig. 7c). In neo-
nates, mRNA levels of the transgenic arENaC seem to be in
the same range (or even higher) as the endogenous aENaC
(Fig. 8 B and F), whereas they are lower in the adult (Fig. 8
H and J). Northern blot analysis of adult lung, kidney, and
colon revealed lower mRNA levels of the transgene com-
pared with the endogene (data not shown). We suggest that,
in surviving aENaC(2y2)Tg, transgene expression is suf-
ficient to restore ENaC-mediated transport in lung but not
in kidney or colon.
DISCUSSION
PHA-1 is a life-threatening disease characterized by severe
neonatal salt-wasting, hyperkaliemia, metabolic acidosis, and
unresponsiveness to exogenous mineralocorticoid hormones
(24). This disease is caused by diminished aldosterone-
responsive Na1 absorption in the renal distal tubule. Muta-
tions in all three subunits of the epithelial sodium channel (a,
b, and gENaC) have been identified in patients suffering from
this disease (9). The metabolic findings of surviving
aENaC(2y2)Tg mice provide further insight into the role of
the sodium channel (ENaC) in a defective Na1 absorption in
kidney. The clinical course observed in the aENaC(2y2)Tg
mice was similar to that seen in infants with PHA-1. These
infants have no apparent problem with clearance of fetal lung
liquid in the perinatal period and generally present with
clinical symptoms related to metabolic dysfunction only after
the first 48 h of life (24).
Rescue of Perinatal Lethality in aENaC(2y2)Tg Mice.
aENaC(2y2)Tg mice were able to clear fetal liquid from the
air spaces during the perinatal period. This near-normal status
might be due to a higher level of transgene expression in lung
(Fig. 3). Surviving adult aENaC(2y2)Tg mice had normal or
near-normal liquid absorption as determined by water content.
Likewise, the liquid absorptive needs of the adult lung in the
FIG. 2. Survival of aENaC(2y2)Tg mice (A) Survival rate of
aENaC(2y2)mice, aENaC(2y2)Tg mice, and control mice
[aENaC(1y1) and aENaC(1y2) mice, transgenic and nontrans-
genic]. Sixteen complete litters from heterozygous breeding (in total
181 mice) were analyzed [aENaC(1y1), n 5 29; aENaC(1y1) Tg,
n 5 26; aENaC(1y2), n 5 59; aENaC(1y2) Tg, n 5 39; aENaC(2y
2), n 5 10; and aENaC(2y2)Tg, n 5 18]. Dead animals were
collected and recorded daily. (B) Overall survival rate of male [14y22
(64%); n 5 22] vs. female [2y18 (11%); n 5 18] aENaC(2y2)Tg mice.
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resting state were met in aENaC(2y2)Tg lungs although
amiloride-sensitive Na1 transport tended to be lower than in
littermate controls (Fig. 4 b and c). It might well be that
non-ENaC-mediated pathways of Na1 or liquid absorption
may contribute to liquid absorption in the postnatal lung. In
lung, ENaC activity is regulated and highly dependent on
glucocorticoid stimulation (12). As a consequence, aENaC
mRNA levels in lung were decreased markedly in mice defi-
cient for the glucocorticoid receptor. These knockout mice die
soon after birth because of respiratory failure (25).
aENaC(2y2)Tg Mice Exhibit Severe PHA-1. After birth, at
'5–9 days, metabolic factors appeared to be most determining
of survival. aENaC(2y2)Tg mice showed significant meta-
bolic acidosis and urinary Na1 loss compared with littermate
controls whereas at 12 h after birth this group exhibited no
metabolic derangements (Fig. 5 a and b). The significantly
diminished activity of ENaC occurred in the context of a 6-fold
increase in aldosterone levels in adult aENaC(2y2)Tg mice
(Fig. 7c). In the rectum, the aldosterone-induced sodium
FIG. 4. Physiological measurements in lung. Control littermates
(C, light gray column), aENaC(2y2)Tg mice (Tg, black column), and
aENaC(2y2) mice (KO, white column) of different ages. (a) Mean
whole lung water content (wetydry ratio); 12 h: aENaC(2y2) vs.
aENaC(2y2)Tg and control littermates, p, P , 0.05; 5–9 days:
aENaC(2y2)Tg vs. control littermates, p, P , 0.05. (b) Amiloride-
sensitive inhibition of potential difference (DPDamil) in tracheal explants
from 19-day-old fetuses. aENaC(2y2)Tg, n 5 7 vs. control littermates,
n 5 22. (c) Amiloride-sensitive short circuit current (DIscamil) in excised
adult nasal and tracheal epithelium. aENaC(2y2)Tg, n 5 4 vs. control
littermates, n 5 4.
FIG. 5. Physiological parameters in aENaC(2y2)Tg. pH (a) and
bicarbonate measurements (b) and urinary Na1 and K1 measurements
(c and d) in control littermates (C, light gray column), aENaC(2y2)Tg
mice (Tg, black column), and aENaC(2y2) mice (KO, white column) of
different ages. p, P , 0.05; pp, P , 0.01.
FIG. 3. In situ hybridization analysis in lung. Localization of aENaC mRNA and arENaC transgene mRNA in lung of 12-h-old pups. Bright-field
(A, D, and G) and dark-field (B, C, E, F, H, and I) photographs of sections from wild-type (1y1; A, B, and C), aENaC(2y2) (D, E, and F), and
aENaC(2y2)Tg mice (G, H, and I) after hybridization with a antisense (B, E, and H) or a sense (C, F, and I) rENaC 35S-labeled probes.
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transport creates an amiloride-sensitive transepithelial PD that
may serve as an indicator of aldosterone activity. Under
normal salt-diet, wild-type mice (1y1) show circadian varia-
tions of amiloride-sensitive rectal PD. Our aENaC transgenic
mice demonstrated a lower Na1 transport in distal colon (Fig.
7b) and a loss of this cyclic variation despite elevated aldoste-
rone levels (Q.W., E.H., M.B., and J.-D.H., unpublished work).
We conclude that, in aENaC(2y2)Tg, the a subunit is
limiting for the sodium channel and suggest that ENaC-
mediated sodium transport in kidney and colon became aldo-
sterone-insensitive. This insensitivity might be explained by
low expression of the transgene and, consequently, any aldo-
sterone-mediated effect on the protein itself might not be
visible (26). Alternatively, the lack of aldosterone effects might
be due to the absence of corresponding regulatory elements in
the cytomegalovirus promoter.
In the first 2 weeks after birth, we lost 50% of our
aENaC(2y2)Tg mice that exhibited severe PHA-1 symptoms
including metabolic acidosis, urinary salt-wasting, and growth
retardation (Fig. 6). It seems that this postnatal period is quite
sensitive to electrolyte disturbances as observed in mice defi-
cient for the mineralocorticoid receptor. These mice die
around day 9 due to electrolyte disturbances despite elevated
plasma aldosterone levels (27).
Adult aENaC(2y2)Tg Mice Escape from a Severe PHA-1.
The metabolic profiles of our aENaC(2y2)Tg mice changed
with age. In contrast to the metabolic acidosis observed in
newborn aENaC knockout mice (at 12 h), aENaC(2y2)Tg
mice exhibited no metabolic derangement (Fig. 5a). However,
by 5–9 days, the aENaC(2y2)Tg group showed significant
metabolic acidosis and urinary Na1 loss compared with litter-
mate controls. When studied in adulthood, metabolic prob-
lems were no longer evident in aENaC(2y2)Tg survivors
(Fig. 5); they had normal blood gases and normal serum and
urinary electrolyte concentrations despite elevated aldoste-
rone levels (Fig. 7c). In patients with PHA-1, supplemental
Na1 requirements diminish over time, but the mechanism of
this apparent change in renal Na1 handling is not yet well
understood (28). Salt and water homeostasis in adult life may
be mediated by alternative (i.e., non-ENaC-mediated) paths of
sodium and water absorption in the kidney, colon, and lung.
Alternatively, salt-intake might change as well with age.
Partial restoration of Na1 transport in aENaC(2y2)Tg
mice resulted in a model that mimics several clinical features
of PHA-1. This model may provide opportunities for further
study of aldosterone-sensitive Na1 absorption and paths of
Na1 and water transport that are not mediated by ENaC. Our
aENaC(2y2)Tg mice allow the study of physiologic conse-
FIG. 7. Bioelectric measurements (a and b) and hormone levels (c)
of control (C, light gray column) and aENaC(2y2) Tg mice (Tg, black
column); mean 6 SEM. (a) Amiloride-sensitive short circuit current
(DIscamil) in fetal colon epithelia (19 days old). Responses to intra-
cellular cAMP stimulant, forskolin were similar in both groups. (b) In
vivo measurements of amiloride-sensitive rectal PD (DPDamil) in adult
male aENaC(2y2)Tg and aENaC(1y1) mice. p, P , 0.001. (c)
Plasma corticosterone levels (mM) (left columns) and plasma aldo-
sterone levels (nM) (right columns) in adult aENaC(2y2)Tg vs.
control littermates [aENaC(1y1); p, P , 0.001].
FIG. 6. Growth curve of aENaC(2y2)Tg mice. Growth curve of
male aENaC(2y2)Tg mice (closed circles) and male littermate
controls (1y1; open squares). Mice were weighed once a week on the
same day and time.
FIG. 8. In situ hybridization analysis in kidney. Bright-field (Left)
and dark-field (Right) photographs of kidney sections from 12-h-old
pups. A and B, (1y1), wild-type; C and D, (2y2), aENaC(2y2); E
and F, (2y2)Tg, aENaC(2y2)Tg from adult; G and H, (1y1)
wild-type; and I and J, (2y2)Tg, aENaC(2y2)Tg after hybridization
with aENaC antisense probe (right columns).
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quences of this altered expression and the molecular analysis
of the regulatory cascade controlling the activity of this sodium
channel. ENaC channel activity derived from transgene ex-
pression in the aENaC(2y2)Tg mice provides a similar
amount of Na1 absorptive function in the critical Na1-
absorbing organs, like lung, kidney, and colon, as seen in
PHA-1 patients.
It will be interesting to study whether PHA-1 in our
aENaC(2y2)Tg mice confers salt-resistance. Following
breeding with hypertensive mouse strains should allow analysis
of the effect of salt resistance (at a genetic level) on the control
of blood pressure.
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Mech. Dev. 42, 49–65.
19. Koopman, P., Gubbay, J., Vivian, N., Goodfellow, P. & Lovell-
Badge, R. (1991) Nature (London) 351, 117–120.
20. Burch, L. H., Talbot, C., Knowles, M. R., Canessa, C., Rossier,
B. & Boucher, R. C. (1995) Am. J. Physiol. 269, C511–C518.
21. Barker, P. M. & Gatzy, J. T. (1993) Am. J. Physiol. 265, L512–
L517.
22. Grubb, B. R. (1995) Am. J. Physiol. 268, G505–G513.
23. Krumlauf, R., Chapman, V. M., Hammer, R. E., Brinster, R. &
Tilghmam, S. M. (1986) Nature (London) 319, 224–226.
24. Cheek, D. B. & Perry, J. W. (1957) Arch. Dis. Child. 33, 252–256.
25. Cole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K.,
Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K.
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